Saturday 23 June 2012

Heterocyclic compounds with cxcr3 antagonist activity

06/21/12 - Class 514 Info Monitor Keywords Archive Organizer Account | Prev - Next

SEARCH FreshPatents: Monitor Keywords | Custom RSS


Abstract: or a pharmaceutically acceptable salt, solvate or ester thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non limiting example(s) include,

Read more ...

No comments:

Post a Comment